ENIGMA Brain Morphometry in CHR-P-Risk Enrichment and Antipsychotics

JAMA Psychiatry. 2024 Apr 1;81(4):427-428. doi: 10.1001/jamapsychiatry.2023.5611.

Authors

Andrea Raballo^{1

2}, Michele Poletti³, Antonio Preti⁴

Affiliations

¹ Faculty of Biomedical Sciences, University of Southern Switzerland, Lugano, Switzerland.
² Cantonal Sociopsychiatric Organisation, Mendrisio, Switzerland.
³ Department of Mental Health and Pathological Addiction, Child and Adolescent Neuropsychiatry Service, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
⁴ Department of Neuroscience, University of Turin, Turin, Italy.

PMID: 38353961
DOI: 10.1001/jamapsychiatry.2023.5611

No abstract available

MeSH terms

Antipsychotic Agents* / pharmacology
Antipsychotic Agents* / therapeutic use
Brain
Humans
Psychotic Disorders* / drug therapy

Substances

Antipsychotic Agents